Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,951 | 242 | 99.2% |
| Education | $29.94 | 2 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $653.90 | 38 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $470.00 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $354.81 | 31 | $0 (2024) |
| Novo Nordisk Inc | $334.04 | 22 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $286.29 | 15 | $0 (2024) |
| Amgen Inc. | $273.28 | 13 | $0 (2024) |
| PFIZER INC. | $257.73 | 15 | $0 (2024) |
| ABBVIE INC. | $205.08 | 25 | $0 (2024) |
| GlaxoSmithKline, LLC. | $188.23 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $118.67 | 9 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,016 | 45 | AstraZeneca Pharmaceuticals LP ($157.98) |
| 2023 | $194.25 | 9 | Amgen Inc. ($49.98) |
| 2022 | $862.16 | 57 | Merck Sharp & Dohme LLC ($230.53) |
| 2021 | $881.52 | 63 | AstraZeneca Pharmaceuticals LP ($167.94) |
| 2020 | $439.27 | 26 | AstraZeneca Pharmaceuticals LP ($144.08) |
| 2019 | $234.46 | 15 | Novo Nordisk Inc ($45.28) |
| 2018 | $118.66 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($37.21) |
| 2017 | $234.01 | 21 | Novo Nordisk Inc ($106.51) |
All Payment Transactions
244 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: RESPIRATORY | ||||||
| 12/17/2024 | Tactile Systems Technology Inc | Flexitouch Plus (Device), Entre Plus | Food and Beverage | In-kind items and services | $19.23 | General |
| Category: PNEUMATIC COMPRESSOR | ||||||
| 12/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.20 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/02/2024 | iRhythm Technologies, Inc. | ZIO XT Patch (Device), Zio monitor | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/11/2024 | PFIZER INC. | PAXLOVID (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/05/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.41 | General |
| 10/28/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/08/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: VACCINE | ||||||
| 10/07/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.12 | General |
| Category: Obesity | ||||||
| 09/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $33.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/24/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: DIABETES | ||||||
| 09/22/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $20.74 | General |
| Category: PAIN | ||||||
| 09/10/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Obesity | ||||||
| 09/10/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $25.09 | General |
| Category: VACCINE | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.55 | General |
| Category: DIABETES | ||||||
| 07/09/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/08/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.52 | General |
| Category: Respiratory | ||||||
| 07/02/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $30.97 | General |
| Category: DIABETES | ||||||
| 07/02/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/25/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: Not Applicable | ||||||
| 06/24/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $21.11 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,450 | 3,746 | $598,385 | $143,581 |
| 2022 | 27 | 2,276 | 3,329 | $449,204 | $131,795 |
| 2021 | 29 | 2,153 | 3,088 | $397,793 | $122,146 |
| 2020 | 29 | 2,139 | 3,174 | $400,483 | $111,038 |
All Medicare Procedures & Services
117 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 271 | 532 | $219,510 | $54,830 | 25.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 200 | 200 | $123,000 | $29,647 | 24.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 154 | 233 | $68,260 | $17,781 | 26.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 19 | 19 | $20,125 | $5,053 | 25.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 56 | 56 | $15,400 | $4,028 | 26.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 146 | 283 | $17,435 | $3,662 | 21.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 153 | 306 | $13,250 | $3,138 | 23.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 161 | 322 | $10,250 | $2,683 | 26.2% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 125 | 161 | $11,950 | $2,650 | 22.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 70 | 70 | $6,650 | $2,519 | 37.9% |
| 0241U | Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | Office | 2023 | 16 | 17 | $9,520 | $2,376 | 25.0% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 12 | 12 | $9,480 | $2,288 | 24.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 150 | 289 | $9,625 | $2,182 | 22.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 139 | 145 | $22,120 | $1,631 | 7.4% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 123 | 158 | $6,955 | $1,397 | 20.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 72 | 106 | $4,940 | $984.94 | 19.9% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 47 | 48 | $4,080 | $864.96 | 21.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 58 | 121 | $2,905 | $666.55 | 22.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 42 | 45 | $3,150 | $658.23 | 20.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 18 | 18 | $1,710 | $647.64 | 37.9% |
| 82746 | Folic acid level, serum | Office | 2023 | 38 | 42 | $2,940 | $605.59 | 20.6% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 58 | 121 | $2,305 | $604.02 | 26.2% |
| 87086 | Bacterial colony count, urine | Office | 2023 | 42 | 64 | $3,200 | $506.24 | 15.8% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 25 | 26 | $1,690 | $347.36 | 20.6% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 67 | 93 | $1,395 | $300.53 | 21.5% |
About Dr. Jeffrey Caruso, D.O
Dr. Jeffrey Caruso, D.O is a Family Medicine healthcare provider based in East Meadow, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/12/2006. The National Provider Identifier (NPI) number assigned to this provider is 1235290677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jeffrey Caruso, D.O has received a total of $3,981 in payments from pharmaceutical and medical device companies, with $1,016 received in 2024. These payments were reported across 244 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,951).
As a Medicare-enrolled provider, Caruso has provided services to 9,018 Medicare beneficiaries, totaling 13,337 services with total Medicare billing of $508,560. Data is available for 4 years (2020–2023), covering 117 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location East Meadow, NY
- Active Since 12/12/2006
- Last Updated 07/09/2007
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1235290677
Products in Payments
- FARXIGA (Drug) $434.26
- JARDIANCE (Drug) $273.02
- ENTRESTO (Drug) $206.72
- BELSOMRA (Drug) $196.66
- LEQVIO (Drug) $148.09
- TRELEGY ELLIPTA (Drug) $147.25
- ELIQUIS (Drug) $124.12
- UBRELVY (Drug) $121.38
- Victoza (Drug) $107.84
- Aimovig (Biological) $99.84
- Otezla (Drug) $95.75
- JANUVIA (Drug) $95.30
- DIFICID (Drug) $93.76
- XARELTO (Drug) $91.01
- GARDASIL (Biological) $83.38
- Vascepa (Drug) $83.22
- VRAYLAR (Drug) $78.91
- Kerendia (Drug) $70.27
- Dayvigo (Drug) $69.19
- Livalo (Drug) $67.82
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in East Meadow
Dr. Steven Linzer, Do, DO
Family Medicine — Payments: $1,032
Dr. Sebeen Razzaq-Ahmed, D.o, D.O
Family Medicine — Payments: $398.97
Smiley Sharma, Do, DO
Family Medicine — Payments: $347.10
Dr. Christopher Calapai, D.o, D.O
Family Medicine — Payments: $150.00
Aliza Raza, D.o, D.O
Family Medicine — Payments: $91.80
Dr. Ramzi Farhat, Do, DO
Family Medicine — Payments: $49.80